Search Results

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensinconverting- enzyme inhibitors: the CHARM-Added trial.

• Authors : McMurray, John J. V.; ostergren, Jan; Swedberg, Karl

Subjects: ACE inhibitors; CHEMICAL inhibitors; HEART failure

• Source: Lancet. 9/6/2003, Vol. 362 Issue 9386, p767-771. 5p. 1 Diagram, 4 Charts, 2 Graphs.

Record details

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

• Authors : McMurray JJV (AUTHOR); Östergren J (AUTHOR); Swedberg K (AUTHOR)

• Source: Lancet. 9/6/2003, Vol. 362 Issue 9386, p767-771. 5p.

Record details

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

• Authors : Pfeffer MA (AUTHOR); Swedberg K (AUTHOR); Granger CB (AUTHOR)

• Source: Lancet. 9/6/2003, Vol. 362 Issue 9386, p759-766. 8p.

Record details

The CHARM programme.

• Authors : Gama, M. G.; Rocha, G.

Subjects: LETTERS to the editor; HEART failure

• Source: Lancet. 11/15/2003, Vol. 362 Issue 9396, p1676-1676. 1p.

Record details